Assignee
GLYCOMIMETICS INC
US·33 granted patents·44 pending applications·369 citations·filing 2002–2023
Top patents by PatentIndex Score
77 records- 0197US8039442B2Compounds and methods for treatment of sickle cell disease or complications associated therewithGLYCOMIMETICS INC·Filed 2008·Granted Oct 18, 2011·23 cites·5 claims
- 0296US8361975B2Compounds and methods for treatment of sickle cell or complications associated therewithGLYCOMIMETICS INC·Filed 2011·Granted Jan 29, 2013·20 cites·6 claims
- 0395US9109002B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2012·Granted Aug 18, 2015·32 cites·15 claims
- 0495US7989601B2Heterobifunctional pan-selectin inhibitorsGLYCOMIMETICS INC·Filed 2010·Granted Aug 2, 2011·28 cites·15 claims
- 0595US7728117B2Heterobifunctional pan-selectin inhibitorsGLYCOMIMETICS INC·Filed 2006·Granted Jun 1, 2010·29 cites·1 claims
- 0694US9867841B2Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cellsGLYCOMIMETICS INC·Filed 2013·Granted Jan 16, 2018·13 cites·13 claims
- 0794US7741312B2Compounds and methods for inhibiting selectin-mediated functionGLYCOMIMETICS INC·Filed 2006·Granted Jun 22, 2010·29 cites·4 claims
- 0894US7517980B2Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from PseudomonasGLYCOMIMETICS INC·Filed 2006·Granted Apr 14, 2009·21 cites·2 claims
- 0993US9796745B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2015·Granted Oct 24, 2017·12 cites·8 claims
- 1092US8026222B2Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosaminesGLYCOMIMETICS INC·Filed 2008·Granted Sep 27, 2011·19 cites·12 claims
- 1192US7060685B2Compounds and methods for inhibiting selectin-mediated functionGLYCOMIMETICS INC·Filed 2003·Granted Jun 13, 2006·44 cites·9 claims
- 1291US11332491B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2020·Granted May 17, 2022·2 cites·14 claims
- 1391US10766916B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2019·Granted Sep 8, 2020·3 cites·16 claims
- 1491US9534009B2Pan-selectin inhibitor with enhanced pharmacokinetic activityGLYCOMIMETICS INC·Filed 2014·Granted Jan 3, 2017·16 cites·7 claims
- 1588US10526361B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2017·Granted Jan 7, 2020·5 cites·18 claims
- 1687US11780873B2Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2021·Granted Oct 10, 2023·1 cites·42 claims
- 1787US7964569B2Glycomimetic replacements for hexoses and N-acetyl hexosaminesGLYCOMIMETICS INC·Filed 2007·Granted Jun 21, 2011·19 cites·13 claims
- 1887US7361644B2Specific antagonist for both E- and P-selectinsGLYCOMIMETICS INC·Filed 2004·Granted Apr 22, 2008·25 cites·5 claims
- 1986US11072625B2Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2017·Granted Jul 27, 2021·4 cites·35 claims
- 2085US11707474B2Methods for treating acute myeloid leukemia and related conditionsGLYCOMIMETICS INC·Filed 2019·Granted Jul 25, 2023·3 cites·57 claims
- 2182US11987598B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2022·Granted May 21, 2024·0 cites·65 claims
- 2282US11712446B2Methods of mobilizing marrow infiltrating lymphocytes and uses thereofGLYCOMIMETICS INC·Filed 2018·Granted Aug 1, 2023·1 cites·14 claims
- 2382US10519181B2Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptorsGLYCOMIMETICS INC·Filed 2015·Granted Dec 31, 2019·4 cites·31 claims
- 2479US11197877B2Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonistsGLYCOMIMETICS INC·Filed 2018·Granted Dec 14, 2021·2 cites·53 claims
- 2579US7135301B2Detection and treatment of prostate cancerGLYCOMIMETICS INC·Filed 2002·Granted Nov 14, 2006·12 cites·2 claims
- 2678US2024165139A1Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonistsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 2776US2023365609A1Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 2874US11845771B2Heterobifunctional inhibitors of E-selectin and galectin-3GLYCOMIMETICS INC·Filed 2019·Granted Dec 19, 2023·1 cites·61 claims
- 2973US11878026B2Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonistsGLYCOMIMETICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·29 claims
- 3072US2023414642A1Methods of mobilizing marrow infiltrating lymphocytes and uses thereofGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 3172US2024150388A1Heterobifunctional inhibitors of e-selectin and galectin-3GLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 3269US2023127765A1Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4GLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 3368US7727735B2Detection and treatment of prostate cancerGLYCOMIMETICS INC·Filed 2006·Granted Jun 1, 2010·1 cites·1 claims
- 3468US2023414641A1Methods for treating acute myeloid leukemia and related conditionsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 3563US2014178303A1Heterobifunctional pan-selectin inhibitorsGLYCOMIMETICS INC·Filed 2013·Application pending·0 cites
- 3660US11433086B2Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4GLYCOMIMETICS INC·Filed 2017·Granted Sep 6, 2022·0 cites·12 claims
- 3760US2016289257A1Glycomimetic compounds and methods to inhibit infection by hivGLYCOMIMETICS INC·Filed 2016·Application pending·0 cites
- 3859US2024269157A1Compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targetingGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 3959US2016361332A1Heterobifunctional pan-selectin inhibitorsGLYCOMIMETICS INC·Filed 2016·Application pending·0 cites
- 4058US2009176717A1Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonasGLYCOMIMETICS INC·Filed 2007·Application pending·0 cites
- 4157US2023364277A1E-selectin targeting agentsGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 4257US2024417420A1Polar cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 4357US2014073594A1Glycomimetic compounds and methods to inhibit infection by hivGLYCOMIMETICS INC·Filed 2013·Application pending·0 cites
- 4455US2004219158A1Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteriaGLYCOMIMETICS INC·Filed 2003·Application pending·0 cites
- 4555US2024270724A1Galectin-3 inhibiting c-glycosidesGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 4655US2024287121A1Galectin-3 inhibiting c-glycoside oximesGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 4753US2023167150A1Cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 4853US2023218649A1Compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targetingGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 4953US2023167149A1Cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 5053US2004096396A1Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesisGLYCOMIMETICS INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →